Archives
-
EZH1/EZH2 Inhibition Potentiates Adoptive T Cell Immunothera
2026-07-17
The referenced study demonstrates that dual inhibition of EZH1 and EZH2 reprograms tumor cells to a more immunogenic state, significantly improving the efficacy of CAR-T and TCR-T cell therapies across multiple cancer models. These findings highlight the potential of epigenetic modulation to overcome resistance in adoptive cell therapies and inform protocol development for lymphoma and solid tumor research.
-
Arrb2 Promotes M2 Macrophage Polarization to Alleviate Hepat
2026-07-17
This study elucidates the role of hepatocyte Arrb2 in promoting M2 macrophage polarization through upregulation of 6-ketoLCA, leading to significant protection against hepatic ischemia–reperfusion injury (IRI). These findings introduce a novel immunometabolic axis with implications for liver transplantation and inflammation resolution.
-
HyperScribe™ Poly (A) Tailing Kit: Precision mRNA Capping fo
2026-07-16
Discover how the HyperScribe™ Poly (A) Tailing Kit empowers precise mRNA polyadenylation to enhance stability and translation efficiency in advanced therapeutic research. This article uniquely bridges biochemical mechanism with translational assay design.
-
Enhancing mRNA Loading in Kidney-Targeted Nanoparticles via
2026-07-16
This study systematically investigates how incorporating different excipients affects the mRNA loading capacity of mesoscale nanoparticles aimed at kidney-targeted delivery. The findings demonstrate that excipients such as DOTAP, trehalose, and calcium acetate can significantly improve mRNA encapsulation efficiency and maintain nanoparticle characteristics essential for renal targeting, suggesting new avenues for optimizing nucleic acid delivery systems.
-
Lypressin Acetate: Protocols and Applications in Vasopressin
2026-07-15
Lypressin acetate stands out as a versatile vasopressin analog, offering researchers robust control over antidiuretic and vasopressor signaling with proven stability and safety. This guide delivers actionable workflow enhancements, troubleshooting strategies, and real-world use cases—bridging endocrine, cardiovascular, and emerging antiviral research domains.
-
EPI-001: Redefining Androgen Receptor Inhibition in CRPC and
2026-07-15
Explore how EPI-001, a potent androgen receptor N-terminal domain inhibitor, is transforming prostate cancer and triple-negative breast cancer research. This article reveals advanced mechanistic insights and practical assay guidance, setting it apart from prior reviews.
-
ac4C-Modified lncRNA Gm26917 Enhances Translation in FGSCs
2026-07-14
This study uncovers how N4-acetylcytidine (ac4C) modification on the long noncoding RNA Gm26917 governs translational efficiency in female germline stem cells (FGSCs) by recruiting ribosomal protein mRNA through EEF1A1. The work establishes a novel ac4C-lncRNA axis in FGSC maintenance, providing new mechanistic insight into RNA modification and fertility regulation.
-
ApexPrep DNA Plasmid Miniprep Kit: Precision for AML Researc
2026-07-14
The ApexPrep DNA Plasmid Miniprep Kit delivers high-yield, molecular biology grade plasmid DNA with reproducibility essential for complex gene regulation studies, such as those targeting AML mechanisms. Its streamlined protocol and advanced buffer system make it a top choice for both routine and challenging plasmid extractions.
-
Photoreceptor c-Fos-Adam17 Axis Suppresses Pathological Reti
2026-07-13
This study uncovers how rod photoreceptors suppress abnormal retinal blood vessel growth by regulating Adam17 transcription through c-Fos, using an oxygen-induced retinopathy mouse model. The findings reveal a targeted pathophysiological mechanism in retinopathy of prematurity and suggest precise molecular targets for future therapeutic strategies.
-
PINK1/Park2-Mediated Mitophagy Attenuates NAFLD Pathology
2026-07-13
The study by Han et al. provides mechanistic evidence that activation of PINK1/Park2-mediated mitophagy alleviates mitochondrial dysfunction and lipid accumulation in non-alcoholic fatty liver disease (NAFLD) models. By manipulating Park2 expression, the authors demonstrate mitophagy as a promising therapeutic axis for NAFLD intervention.
-
Applied Workflows with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)
2026-07-12
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) delivers dual-fluorescence tracking and immune-evasive chemistry for quantitative mRNA delivery and translation efficiency assays. Its Cy5 and EGFP readouts streamline optimization, troubleshooting, and advanced nanoparticle validation in modern gene therapy workflows.
-
Lipo3K Transfection Reagent: High Efficiency for Difficult C
2026-07-10
Lipo3K Transfection Reagent empowers researchers to achieve robust nucleic acid delivery—even in challenging and difficult-to-transfect cell lines—thanks to its innovative cationic lipid formulation and low cytotoxicity profile. Its dual-component system and unique nuclear delivery enhancer support advanced gene expression and RNA interference workflows, making it an exceptional Lipofectamine alternative for demanding experimental needs.
-
Semi-Automated Screening of Fast-Dissociating Anti-V5 Antibo
2026-07-09
Miyoshi et al. developed a semi-automated single-molecule microscopy platform to directly screen fast-dissociating, highly specific monoclonal antibodies from hybridoma cultures. This innovation advances the use of epitope tags like the V5 sequence for dynamic protein detection and multiplexed super-resolution imaging.
-
EdU Flow Cytometry Assay Kits (Cy5): Protocol and Best Pract
2026-07-09
The EdU Flow Cytometry Assay Kits (Cy5) (SKU K1078) enable efficient, sensitive detection of cell proliferation by measuring S-phase DNA synthesis using click chemistry. This assay is ideal for applications where preservation of cell structure and compatibility with multiplexing are essential, such as in cancer research or genotoxicity assessment. It should not be used in workflows incompatible with copper-catalyzed reactions or when DNA denaturation is required for downstream analysis.
-
RG108: Redefining Epigenetic Modulation in Translational Res
2026-07-08
This article dissects the mechanistic sophistication and translational promise of RG108, a potent DNA methyltransferase inhibitor from APExBIO. By weaving together foundational biology, experimental validation, and practical workflow guidance, it offers strategic insights for researchers pursuing epigenetic gene regulation and tumor suppressor gene reactivation in cancer and stem cell models. Drawing on comparative studies and best-practice protocols, the piece elucidates how RG108’s non-covalent mechanism and selective demethylation are redefining experimental possibilities in the field.